Immutep Ownership
| IMMP Stock | USD 1.71 0.01 0.59% |
Shares in Circulation | First Issued 2007-12-31 | Previous Quarter 121.6 M | Current Value 145.3 M | Avarage Shares Outstanding 154.8 M | Quarterly Volatility 297.5 M |
Immutep Stock Ownership Analysis
The book value of the company was currently reported as 0.12. The company recorded a loss per share of 0.21. Immutep Ltd ADR last dividend was issued on the 28th of December 2016. The entity had 3:10 split on the 28th of December 2016. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To learn more about Immutep Ltd ADR call Marc Voigt at 61 2 8315 7003 or check out https://www.immutep.com.Immutep Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Immutep is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immutep Ltd ADR backward and forwards among themselves. Immutep's institutional investor refers to the entity that pools money to purchase Immutep's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tower Research Capital Llc | 2025-03-31 | 25.1 K | Ubs Group Ag | 2025-03-31 | 24 K | Geode Capital Management, Llc | 2025-03-31 | 18.7 K | Millennium Management Llc | 2025-03-31 | 15.4 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 14.3 K | Xtx Topco Ltd | 2025-03-31 | 11.1 K | Bank Of America Corp | 2025-03-31 | 2.2 K | Gamma Investing Llc | 2025-06-30 | 602 | Royal Bank Of Canada | 2025-03-31 | 197 | Blackrock Inc | 2025-03-31 | 648.3 K | Meridian Wealth Management, Llc | 2025-03-31 | 386.6 K |
Immutep Outstanding Bonds
Immutep issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Immutep Ltd ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Immutep bonds can be classified according to their maturity, which is the date when Immutep Ltd ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US45258LAA52 Corp BondUS45258LAA52 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Pair Trading with Immutep
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.Moving against Immutep Stock
| 0.41 | NKTR | Nektar Therapeutics | PairCorr |
| 0.39 | CGEN | Compugen | PairCorr |
| 0.39 | BAC-PL | Bank of America | PairCorr |
| 0.33 | MRK | Merck Company Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.